Aleafia Health Inc (OTCMKTS: ALEAF) has seen an incredible run-up over the past 2 months quickly attracting a fast growing shareholder base which has transformed Aleafia into one of the top most traded cannabis stocks on the planet.
Cannabis is a great place to be; according to a recent report from Arcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe and spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%. The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. Of course much of this hinges on how laws progress.
Aleafia Health Inc (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) is a leading, vertically integrated medical cannabis company with a unique focus on delivering quality patient care from “seed” to “sale.” Aleafia is a licensed producer of medical cannabis in Canada pursuant to the Access to Cannabis for Medical Purposes Regulations.
Aleafia has been making big moves in 2018; the Company recently acquired a modern, fully automated 160,000 sq. ft. greenhouse in the Niagara Region. Renovations at the facility are already underway, with the facility expected to be retrofitted and licensed before the end of 2018, with a first harvest expected in spring 2019. The facility will join Aleafia’s existing licensed facility in Scugog, Ontario, which is expected to undergo a 150,000 sq. ft. expansion. According to Aleafia the greenhouse will be fully operational last this year.
Aleafia operates the largest brick and mortar medicinal cannabis clinic network in Canada under the Canabo Medical Clinic brand with 22 nationwide cannabis clinics and growing, which is staffed by licensed, practicing physicians. Aleafia has obtained over 50,000 unique patients and maintains the largest medical cannabis patient data set in Canada.
To Find out the inside Scoop on Aleafia Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
The Company recently completed its second harvest at its Port Perry cultivation facility. The crop will be sold to a licensed producer in the near term, providing further immediate revenue for Aleafia. The company also completed its first sale of high-quality medical cannabis earlier this week, in a transaction with CannTrust Holdings Inc.
In August Aleafia reported Record Revenue in Q2; Revenue for the three months ended June 30th, 2018 totaled $1,207,886. The Company was also recently added to the Horizons Marijuana Life Sciences ETF (HMMJ:TSX). HMMJ is the world’s first and largest Exchange Traded Fund (ETF) offering direct exposure to North American publicly listed life sciences companies with significant business activities in the marijuana industry.
Earlier this month Aleafia submitted a finalized application to list its common shares on the NASDAQ stock exchange. Listing on a major United States stock exchange will provide unparalleled liquidity and place Aleafia among a small handful of Canadian cannabis companies. The U.S. based NASDAQ stock market is the second largest stock exchange by market capitalization.
On October 9 Aleafia announced it will move forward with an industry first secure, low-cost outdoor cannabis grow. The company has now obtained local regulatory approval for a 60,000 kg capacity expansion at its Port Perry cultivation facility. Pending standard Health Canada approvals, Aleafia will build an innovative, secure outdoor cultivation site, leading to significant reduction in up front capital investments, operating expenses and ultimately, a lower cost per gram output. The Port Perry site is currently home to a Health Canada licensed, fully operational indoor cultivation facility. The expansion will be on 30 acres of land adjacent to the cultivation facility already owned by Aleafia.
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $335 million market valuation Aleafia is sitting on a war chest of $29 million CAD in the treasury. The Company boats virtually no debt and fast growing revenues recently reporting record Q2 Revenue of $1.2 million. Aleafia is one exciting cannabis company making big moves; the Company operates the largest brick and mortar medicinal cannabis clinic network in Canada under the Canabo Medical Clinic brand and they are uniquely positioned in the booming Canadian cannabis market with 2 facilities and growing capacity expected to reach 38,000 kg by early 2019 and 98,000 kg with Port Perry expansion We will be updating on Aleafia when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Aleafia.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in Aleafia either long or short and we have not been compensated for this article.